Interleukin 6 Mediates the Therapeutic Effects of Adipose-Derived Stromal/Stem Cells in Lipopolysaccharide-Induced Acute Lung Injury

Author:

Zhang Shijia12,Danchuk Svitlana D.1,Bonvillain Ryan W.1,Xu Beibei3,Scruggs Brittni A.12,Strong Amy L.1,Semon Julie A.1,Gimble Jeffrey M.14,Betancourt Aline M.1,Sullivan Deborah E.15,Bunnell Bruce A.126

Affiliation:

1. Center for Stem Cell Research and Regenerative Medicine Tulane University School of Medicine, New Orleans, Louisiana, USA

2. Department of Pharmacology Tulane University School of Medicine, New Orleans, Louisiana, USA

3. Department of Pathology and Laboratory Medicine Tulane University School of Medicine, New Orleans, Louisiana, USA

4. Stem Cell Biology Laboratory Pennington Biomedical Research Center, Louisiana State University System, Louisiana, USA

5. Department of Microbiology and Immunology Tulane University School of Medicine, New Orleans, Louisiana, USA

6. Division of Regenerative Medicine Tulane National Primate Research Center, Covington, Louisiana, USA

Abstract

Abstract Adipose-derived stromal/stem cells (ASCs) have anti-inflammatory as well as immunosuppressive activities and are currently the focus of clinical trials for a number of inflammatory diseases. Acute lung injury (ALI) is an inflammatory condition of the lung for which standard treatment is mainly supportive due to lack of effective therapies. Our recent studies have demonstrated the ability of both human ASCs (hASCs) and mouse ASCs (mASCs) to attenuate lung damage and inflammation in a rodent model of lipopolysaccharide-induced ALI, suggesting that ASCs may also be beneficial in treating ALI. To better understand how ASCs may act in ALI and to elucidate the mechanism(s) involved in ASC modulation of lung inflammation, gene expression analysis was performed in ASC-treated (hASCs or mASCs) and control sham-treated lungs. The results revealed a dramatic difference between the expression of anti-inflammatory molecules by hASCs and mASCs. These data show that the beneficial effects of hASCs and mASCs in ALI may result from the production of different paracrine factors. Interleukin 6 (IL-6) expression in the mASC-treated lungs was significantly elevated as compared to sham-treated controls 20 hours after delivery of the cells by oropharyngeal aspiration. Knockdown of IL-6 expression in mASCs by RNA interference abrogated most of their therapeutic effects, suggesting that the anti-inflammatory properties of mASCs in ALI are explained, at least in part, by activation of IL-6 secretion. Stem Cells  2014;32:1616–1628

Funder

Tulane University

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Reference35 articles.

1. The acute respiratory distress syndrome;Ware;N Engl J Med,2000

2. Acute respiratory distress syndrome and acute lung injury;Dushianthan;Postgrad Med J,2011

3. Battling Inflammation in acute lung injury and acute respiratory distress syndrome: Stem cell-based therapy targeting the root cause of acute lung injury;Bonvillain;J Pulmonar Respirat Med,2011

4. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice;Gupta;J Immunol,2007

5. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung;Lee;Proc Natl Acad Sci USA,2009

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3